Targeted Molecular Diagnostics, LLC
1Patents
0Active
1Granted
21Portfolio score
Filing activity: Sep 9, 2005 → Sep 9, 2005
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7862995B2 | Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor | Physics | 6 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.